Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
AIDS Res Hum Retroviruses ; 18(6): 435-46, 2002 Apr 10.
Article in English | MEDLINE | ID: mdl-11958687

ABSTRACT

Infection with human immunodeficiency virus type 1 (HIV-1) is associated with dramatic depletion of CD4(+) T cells, the major HIV-1-induced pathogenesis. Apoptosis has been suggested to play an important role for the T cell depletion and a number of mechanisms have been proposed for the apoptosis in T cells. Here, we compared the levels for apoptosis induction in primary peripheral blood mononuclear cells (PBMCs) among several laboratory strains and primary isolates of the HIV-1 subtypes B and E. The results showed that apoptosis in infected PBMCs, preferentially in CD4+ T cell population, became detectable around the time for virus production by flow cytometric terminal transferase dUTP nick end labeling (TUNEL) technique and staining with the nuclear dye Hoechst 33342. The abilities to induce apoptosis in PBMCs were highly variable in individual isolates. The increase of p53 protein in infected PBMCs, which was initiated before virus production, was observed in infected PBMCs and the levels of p53 protein were almost proportional to the rates of the isolates to induced apoptosis. The cells infected and cultured in the presence of Z-VAD-FMK had significantly decreased cell mortalities, indicating that activated caspases also played a significant role in the apoptosis. Thus, HIV-1-induced apoptosis in primary T cells was accompanied by the p53 protein and caspase activation at varied levels in primary isolates.


Subject(s)
Apoptosis , CD4-Positive T-Lymphocytes/physiology , Caspases/physiology , HIV-1/physiology , Tumor Suppressor Protein p53/physiology , Amino Acid Sequence , Cells, Cultured , Humans , In Situ Nick-End Labeling , Molecular Sequence Data , Virus Replication
2.
Virology ; 293(1): 94-102, 2002 Feb 01.
Article in English | MEDLINE | ID: mdl-11853403

ABSTRACT

A significant increase in the CD38(+) population among T lymphocytes has been observed in human immunodeficiency virus type 1 (HIV-1)-infected carriers. We previously reported a higher replication rate of T-tropic HIV-1 in the CD4(+)CD38(+)CD62L(+) than CD38(-) subset under conditions of mitogen stimulation after infection. Here, we revealed a similarly high susceptibility in the CD38(+) subset on culture with conditioned medium containing Th2 cytokine, interleukin (IL)-4 that was produced endogenously from this subset on stimulation with mitogen or anti-CD3 antibody for 3 days. The contribution of IL-4 to the upregulated production of virus in the CD38(+) subset was confirmed by culture of this subset with recombinant human IL-4. In contrast, the rate of replication in the CD38(-) subset was not augmented in the conditioned medium from either subset or with IL-4. However, there were no differences in the surface expression of IL-4 receptor or HIV-1 receptors CD4 and CXCR4 between the two subsets. Thus, the CD4(+)CD38(+)CD62L(+) subset comprises a specific cell population secreting endogenous Th2 cytokine that contributes to the efficient production of T-tropic HIV-1 through upregulation at a certain stage of the viral life cycle, probably after the adsorption step.


Subject(s)
Antigens, CD , Antigens, Differentiation/analysis , CD4-Positive T-Lymphocytes/virology , HIV-1/physiology , Interleukin-4/biosynthesis , L-Selectin/analysis , NAD+ Nucleosidase/analysis , T-Lymphocyte Subsets/virology , Virus Replication , ADP-ribosyl Cyclase , ADP-ribosyl Cyclase 1 , CD4 Antigens/analysis , Humans , Membrane Glycoproteins , Receptors, CXCR4/analysis , Receptors, Interleukin-4/analysis
3.
Vaccine ; 20(7-8): 1181-5, 2002 Jan 15.
Article in English | MEDLINE | ID: mdl-11803080

ABSTRACT

Development of a safe and effective vaccine against human immunodeficiency virus (HIV) is urgent, but many concerns regarding the safety and efficacy of the currently developing vaccines remain. A major hindrance in HIV vaccine development is the genetic diversity, a hallmark of HIV biology, and a poor understanding of how HIV vaccine prevents the emergence of escape variants during infection and progression of AIDS. Here, we developed a method to construct a molecularly cloned viral library. This technique employs a long-range polymerase chain reaction (PCR) to amplify a virtually full-length HIV type 1 (HIV-1) provirus genome from peripheral blood mononuclear cells (PBMCs) infected with CRF01_AE (subtype E) Thai primary isolate. Among randomly selected 93 clones, 41 with a full-length sequence were able to replicate in PBMCs, 5 of which induced strong cytopathic effects. Replication kinetics also showed that the parental virus was intermediate among the clones. Thus, the molecular library prepared by this method showed the quasi-species in infected cells and this method could provide a new possibility for the development of an order-made therapeutic vaccine against HIV-1.


Subject(s)
Gene Library , HIV-1/genetics , AIDS Vaccines , Genome, Viral , Leukocytes, Mononuclear/virology , Polymerase Chain Reaction , Transfection , Virus Replication
SELECTION OF CITATIONS
SEARCH DETAIL
...